Kura Oncology (KURA) Return on Capital Employed (2011 - 2026)
Kura Oncology (KURA) reported Return on Capital Employed of 3.45% for Q1 2026, up 2463.0% year-over-year from 0.13% in Q1 2025, and down 212.45% quarter-over-quarter from 1.1% in Q4 2025.
Kura Oncology (KURA) Return on Capital Employed (2011 - 2026) Analysis & Trends
Kura Oncology (KURA) has 7 years of Return on Capital Employed data on file, last reported at 3.45% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 3.45%, up 2463.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.45% (up 2463.0% YoY), and the FY2025 annual result was 48.02%, down 1128.0% from the prior year.
- Return on Capital Employed retreated to 3.45% in Q1 2026 per KURA's latest filing, from 1.1% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 1.1% in Q4 2025 and troughed at 40.57% in Q3 2025.
- A 3-year average of 22.43% and a median of 28.08% in 2025 frame the typical range for Return on Capital Employed.
- On a YoY basis, Return on Capital Employed climbed as much as 3040 bps in 2025 and fell as far as 1760 bps in 2025.
- A 3-year view of Return on Capital Employed shows it stood at 31.5% in 2024, then jumped by 96 bps to 1.1% in 2025, then tumbled by 212 bps to 3.45% in 2026.
- Business Quant data shows KURA's Return on Capital Employed at 3.45% in Q1 2026, 1.1% in Q4 2025, and 40.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | -3.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.45% |
| Dec 31, 2025 | -1.10% |
| Sep 30, 2025 | -40.57% |
| Jun 30, 2025 | -33.21% |
| Mar 31, 2025 | -28.08% |
| Dec 31, 2024 | -31.50% |
| Sep 30, 2024 | -33.63% |
| Jun 30, 2024 | -19.87% |
| Mar 31, 2024 | -10.48% |
| Dec 31, 2014 | 1.03% |
| Mar 31, 2013 | 23.00% |
| Dec 31, 2012 | 23.83% |
| Sep 30, 2012 | 26.26% |
| Jun 30, 2012 | 29.96% |
| Mar 31, 2012 | 28.47% |
| Dec 31, 2011 | 35.45% |
| Sep 30, 2011 | 40.02% |
| Jun 30, 2011 | 37.64% |